The healthcare landscape in 2026 has reached a historic turning point as the US Regenerative Medicine Market transitions from a niche research field into the backbone of modern curative care. Currently valued at approximately USD 53.7 billion, the market is expanding at a robust CAGR of 19.2%, propelled by an aging population and the escalating prevalence of chronic diseases like type 1...